Strain Profile · NCBI Strain Taxon 880633
Save

Lactobacillus helveticus R0052

◐ Food-origin
Sequenced
Public genome assembly available

Lactobacillus helveticus R0052 is most often studied in combination with Bifidobacterium longum R0175, a pairing investigated in the context of the gut-brain axis (the bidirectional communication network linking intestinal microbes to the central nervous system). Animal model work has explored mood-related outcomes following this combination, and at least one small human randomized controlled trial examined brain responses to emotional tasks, though the multi-strain design means outcomes cannot be attributed to R0052 alone. Additional human RCTs have assessed the broader combination in healthy adults and in infants. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 101 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+3 more systems

Symptoms in the research

Share of this strain's 58 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+10 more symptoms

Research

128 papers reference this strain in the probiotic database.

Match confidence
2025 IN_VITRO
Lactobacillus helveticus Encapsulated by Ionic Gelation with Sodium Alginate: A Controlled Release Study in Peanut Butter
· ACS Food Science & Technology
2025 RCT
Pilot Trial of Probiotics in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Approach
· Progress In Microbes & Molecular Biology
2025 RCT
A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers
· International Journal of Molecular Sciences
2025 IN_VITRO
Restoring Balance: Probiotic Modulation of Microbiota, Metabolism, and Inflammation in SSRI-Induced Dysbiosis Using the SHIME® Model
· Pharmaceuticals
2025 ANIMAL
Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 administration to Long–Evans rats has interactive effects with sex and diet on anxiety-related feeding behaviors and specific endocrine outcomes
· Physiology & Behavior
2025 ANIMAL
Lactobacillus helveticus R0052 attenuates DSS-induced colitis via modulation of gut microbiota, intestinal metabolites and immunological profiles in a mouse model
· Microbial Pathogenesis
2025 RCT
Does isovaleric acid play a key role in the interaction between probiotics and antidepressants? A secondary analysis of a randomized clinical trial
· Computational and Structural Biotechnology Journal
2024 ANIMAL
Probiotics Alter the Microbial and Behavioral Consequences of Methamphetamine Exposure in a Sex-Selective Manner
· Psychoactives
2024 IN_VITRO
Development of functional peanut paste containing lactobacillus helveticus encapsulated by ionic gelification
· LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
2024 RCT
The effect of probiotic-fortified kefir on cardiovascular risk factors in elderly population: a double-blind, randomized, placebo-controlled clinical trial
· BMC Nutrition
2023 OBSERVATIONAL
USE OF PROBIOTICS IN ALLERGIC RHINITS: A PILOT STUDY
· Journal of Contemporary Diseases and Advanced Medicine
2023 OBSERVATIONAL
Total Transit Time and Probiotic Persistence in Healthy Adults: A Pilot Study
· Journal of Neurogastroenterology and Motility
2023 RCT
Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
· Frontiers in Gastroenterology
2023 RCT
Psychobiotic Effects on Anxiety Are Modulated by Lifestyle Behaviors: A Randomized Placebo-Controlled Trial on Healthy Adults
· Nutrients
2023 IN_VITRO
Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME
· Nutrients
2022 RCT
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
· Microorganisms
2022 RCT
Promises for patients with disturbed gut-brain axis signalling: Does the intake of a probiotic mixture improve mental health of healthy subjects?
·
2022 ANIMAL
The effects of antimicrobials and lipopolysaccharide on acute immune responsivity in pubertal male and female CD1 mice
· Comprehensive Psychoneuroendocrinology
2022 RCT
Probiotic Mixture Containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum Affects Brain Responses Toward an Emotional Task in Healthy Subjects: A Randomized Clinical Trial
· Frontiers in Nutrition
2022 IN_VITRO
In Vitro Probiotic Modulation of the Intestinal Microbiota and 2′Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age
· Microorganisms
Browse all 128 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
    · Frontiers in Gastroenterology · 2023
    PMID 41821821 →
  2. [2]
    Promises for patients with disturbed gut-brain axis signalling: Does the intake of a probiotic mixture improve mental health of healthy subjects?
    · · 2022
    Source →
  3. [3]
    O3 Changes in gut microbiota after synbiotic supplementation in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
    · Oral Presentations · 2020
    Source →
  4. [4]
    Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study
    · Beneficial Microbes · 2019
    PMID 31965842 →
  5. [5]
    Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial
    · Beneficial Microbes · 2017
    PMID 28555502 →
  6. [6]
    Probiotic Lacidofil® STRONG Mitigates the Antibiotic‐Induced Alteration of the Fecal microRNA Signature in Healthy Humans
    · The FASEB Journal · 2016
    Source →
  7. [7]
    Experience using probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in children with burn injuries
    Досвід використання пробіотичних штамів Lactobacillus acidophilus R0052 та Lactobacillus rhamnosus R0011 у дітей з опіковою травмою
    · GASTROENTEROLOGY · 2016
    Source →
  8. [8]
    Amélioration de la croissance et de la survie en conditions gastrointestinales de bactéries probiotiques sensibles à l'oxygène, microencapsulées ou non, en présence d'un extrait de thé vert
    · · 2015
    Source →
  9. [9]
    A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011
    · Beneficial Microbes · 2011
    PMID 22146691 →
  10. [10]
    Randomized, placebo-controlled trial on clinical and immunologic effects of probiotic containing Lactobacillus rhamnosus R0011 and L. helveticus R0052 in infants with atopic dermatitis
    · Microbial Ecology in Health and Disease · 2009
    Source →